Glucotrack (GCTK) Cost of Revenue (2016 - 2020)
Historic Cost of Revenue for Glucotrack (GCTK) over the last 5 years, with Q4 2020 value amounting to $141000.0.
- Glucotrack's Cost of Revenue rose 977.46% to $141000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $415000.0, marking a year-over-year decrease of 2757.42%. This contributed to the annual value of $122000.0 for FY2023, which is N/A changed from last year.
- Per Glucotrack's latest filing, its Cost of Revenue stood at $141000.0 for Q4 2020, which was up 977.46% from $93000.0 recorded in Q3 2020.
- Over the past 5 years, Glucotrack's Cost of Revenue peaked at $465814.0 during Q3 2017, and registered a low of -$593026.0 during Q4 2016.
- In the last 5 years, Glucotrack's Cost of Revenue had a median value of $236007.5 in 2017 and averaged $200047.3.
- In the last 5 years, Glucotrack's Cost of Revenue soared by 17775.71% in 2017 and then crashed by 5938.82% in 2019.
- Over the past 5 years, Glucotrack's Cost of Revenue (Quarter) stood at -$593026.0 in 2016, then soared by 177.76% to $461120.0 in 2017, then crashed by 49.02% to $235076.0 in 2018, then tumbled by 45.36% to $128445.0 in 2019, then grew by 9.77% to $141000.0 in 2020.
- Its Cost of Revenue was $141000.0 in Q4 2020, compared to $93000.0 in Q3 2020 and $90000.0 in Q2 2020.